SE454880B - 3-aminoalkyl-1h-indol-5-acetamider, forfarande for framstellning av dessa och en farmaceutisk komposition for behandling av migren - Google Patents

3-aminoalkyl-1h-indol-5-acetamider, forfarande for framstellning av dessa och en farmaceutisk komposition for behandling av migren

Info

Publication number
SE454880B
SE454880B SE8104781A SE8104781A SE454880B SE 454880 B SE454880 B SE 454880B SE 8104781 A SE8104781 A SE 8104781A SE 8104781 A SE8104781 A SE 8104781A SE 454880 B SE454880 B SE 454880B
Authority
SE
Sweden
Prior art keywords
compound
formula
group
indole
solution
Prior art date
Application number
SE8104781A
Other languages
English (en)
Swedish (sv)
Other versions
SE8104781L (sv
Inventor
D E Bays
C F Webb
M D Dowle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8104781L publication Critical patent/SE8104781L/xx
Publication of SE454880B publication Critical patent/SE454880B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
SE8104781A 1980-08-12 1981-08-11 3-aminoalkyl-1h-indol-5-acetamider, forfarande for framstellning av dessa och en farmaceutisk komposition for behandling av migren SE454880B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8026286 1980-08-12

Publications (2)

Publication Number Publication Date
SE8104781L SE8104781L (sv) 1982-02-13
SE454880B true SE454880B (sv) 1988-06-06

Family

ID=10515410

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8104781A SE454880B (sv) 1980-08-12 1981-08-11 3-aminoalkyl-1h-indol-5-acetamider, forfarande for framstellning av dessa och en farmaceutisk komposition for behandling av migren

Country Status (16)

Country Link
US (1) US4650810A (Direct)
JP (1) JPS5764669A (Direct)
AU (1) AU548467B2 (Direct)
BE (1) BE889929A (Direct)
CA (1) CA1169428A (Direct)
CH (1) CH651551A5 (Direct)
DE (1) DE3131728A1 (Direct)
DK (1) DK157920C (Direct)
ES (5) ES504693A0 (Direct)
FR (1) FR2488607A1 (Direct)
IE (1) IE51491B1 (Direct)
IT (1) IT1171449B (Direct)
NL (1) NL8103769A (Direct)
NZ (1) NZ197996A (Direct)
SE (1) SE454880B (Direct)
ZA (1) ZA815540B (Direct)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
GB8607824D0 (en) * 1986-03-27 1986-04-30 Glaxo Group Ltd Chemical compounds
MC2210A1 (fr) * 1990-06-07 1992-11-26 Wellcome Found Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
US5254383A (en) * 1992-09-14 1993-10-19 Allied-Signal Inc. Composites having improved penetration resistance and articles fabricated from same
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
ES2084560B1 (es) * 1994-03-09 1997-01-16 Almirall Lab Procedimiento de preparacion de derivados el indol.
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
JP4897221B2 (ja) * 2002-12-20 2012-03-14 チバ ホールディング インコーポレーテッド アミン類の合成及びその合成のための中間体
EP2120875B1 (en) 2007-02-11 2018-07-11 Map Pharmaceuticals Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
CL2008000838A1 (es) 2007-03-23 2008-10-10 Neuraxon Inc Compuestos derivados de quinolina y tetrahidroquinolina, con actividad inhibidora nos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un dolor de cabeza tal como migrana, dolor cronico, desordenes del sistema nervios
CA2681979A1 (en) 2007-03-29 2008-10-09 Asubio Pharma Co., Ltd. Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same
WO2010151804A1 (en) * 2009-06-26 2010-12-29 Map Pharmaceuticals, Inc. Administration of dihydroergotamine mesylate particles using a metered dose inhaler
AU2012287120B2 (en) 2011-07-22 2017-02-23 The University Of Chicago Treatments for migraine and related disorders
EP2935280A4 (en) 2012-12-21 2016-05-25 Map Pharmaceuticals Inc 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
US4650810A (en) 1987-03-17
ES513933A0 (es) 1984-01-16
ES8301210A1 (es) 1982-12-01
SE8104781L (sv) 1982-02-13
FR2488607A1 (fr) 1982-02-19
DK157920C (da) 1990-08-06
ES8500903A1 (es) 1984-11-01
ES8402268A1 (es) 1984-01-16
BE889929A (fr) 1982-02-11
NL8103769A (nl) 1982-03-01
ES8500902A1 (es) 1984-11-01
FR2488607B1 (Direct) 1984-11-16
ES520785A0 (es) 1984-11-01
AU7399481A (en) 1982-02-18
ES520784A0 (es) 1984-11-01
DK157920B (da) 1990-03-05
ZA815540B (en) 1983-03-30
ES504693A0 (es) 1982-12-01
NZ197996A (en) 1985-08-16
IE811830L (en) 1982-02-12
IE51491B1 (en) 1987-01-07
JPH0247462B2 (Direct) 1990-10-19
DE3131728A1 (de) 1982-03-11
ES520783A0 (es) 1985-05-01
IT8149084A1 (it) 1983-02-11
DK357081A (da) 1982-02-13
IT8149084A0 (it) 1981-08-11
JPS5764669A (en) 1982-04-19
CH651551A5 (fr) 1985-09-30
IT1171449B (it) 1987-06-10
DE3131728C2 (Direct) 1992-04-30
AU548467B2 (en) 1985-12-12
CA1169428A (en) 1984-06-19
ES8504706A1 (es) 1985-05-01

Similar Documents

Publication Publication Date Title
SE454880B (sv) 3-aminoalkyl-1h-indol-5-acetamider, forfarande for framstellning av dessa och en farmaceutisk komposition for behandling av migren
US5159083A (en) Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
AU667107B2 (en) Thiazolylvinylphenyl derivatives
DE69620241T2 (de) Gonadotropin releasing hormon- antagonisten
SE454881B (sv) N-(3-(aminoalkyl)-1h-indol-5-yl-metyl) sulfonamider, forfarande for framstellning av dessa och en farmaceutisk komposition for behandling av migren
FI92397C (fi) Menetelmä valmistaa farmaseuttisesti käyttökelpoisia indolijohdoksia
DE3444572C2 (de) Indolderivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zubereitungen und ihre Verwendung
CZ404191A3 (en) Indole derivative, process of its preparation and pharmaceutical preparations containing thereof
SE448628B (sv) 5-indolamider, farmaceutisk komposition innehallande dessa och forfarande for framstellning av foreningarna
CA2844982A1 (en) Lysophosphatidic acid receptor antagonists
DE69433984T2 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
FR2530625A1 (fr) Derives d'indole, procedes pour leur preparation et compositions pharmaceutiques les contenant
JPH0148896B2 (Direct)
US7442693B2 (en) Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
CH664152A5 (fr) Derives de tetrahydrocarbazolones.
SE454777B (sv) 5-substituerade 3-aminoalkyl-1h-indoler, forfarande for framstellning av dessa och en farmaceutisk komposition for behandling av migren
AU701560B2 (en) 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
FR2574793A1 (fr) Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation
AU715493B2 (en) Selective beta 3 adrenergic agonists
JPH09510706A (ja) ドパミン作動性活性を有するベンゾイミダゾール誘導体
US4153715A (en) Indolyl amino acids useful as antihypertensive agents
CH671017A5 (Direct)
EP1007524B1 (fr) Derives d'indole comme agonistes de 5-ht1b et 5-ht1d
JP2001525398A (ja) 選択的β３アドレナリン作動性アゴニスト
CN118019738A (zh) 作为sting拮抗剂的小分子脲衍生物

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8104781-3

Effective date: 19910315

Format of ref document f/p: F